Literature DB >> 20463600

Effects of IL-2 on MMP expression in freshly isolated human NK cells and the IL-2-independent NK cell line YT.

Karin Edsparr1, Frank M Speetjens, Adri Mulder-Stapel, Ronald H Goldfarb, Per H Basse, Bo Lennernäs, Peter J K Kuppen, Per Albertsson.   

Abstract

Interleukin-2 is an important activation factor for natural killer (NK) cells but its effect on NK cell matrix metalloproteinases (MMP) production and matrix degradation is less well investigated. We have used freshly isolated human NK cells and the IL-2-independent NK cell line, YT, to investigate the effects of IL-2 stimulation on NK cell invasion of Matrigel and on MMP expression and production. In YT cells, we found opposing early and late effects of IL-2 stimulation with an early (2 h) increase in MMP-9 protein level and enhanced migration in the Matrigel invasion assay and by 30 hours a decreased mRNA expression of MMP-2, MMP-9, MMP-13, MT3-MMP, and MT6-MMP. We also found a preculture period of 48 hours with IL-2 to negatively affect YT cell migration. We furthermore found that freshly isolated human NK cells Matrigel invasion was MMP-dependent and it increased in response to IL-2. Importantly, in freshly isolated human NK cells we did not see a downregulation of MMPs after 24 hours IL-2 stimulation, but instead a significant upregulation of MT6-MMP mRNA. Because of the cellular localisation of MT6-MMP, which ensures a focalized proteolytic activity, and its high expression compared with the other MMPs in freshly isolated human NK cells makes it of interest to study further.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20463600      PMCID: PMC2877139          DOI: 10.1097/CJI.0b013e3181d372a0

Source DB:  PubMed          Journal:  J Immunother        ISSN: 1524-9557            Impact factor:   4.456


  20 in total

1.  The phenotypic heterogeneity of human natural killer cells: presence of at least 48 different subsets in the peripheral blood.

Authors:  L E Jonges; P Albertsson; R L van Vlierberghe; N G Ensink; B R Johansson; C J van de Velde; G J Fleuren; U Nannmark; P J Kuppen
Journal:  Scand J Immunol       Date:  2001-02       Impact factor: 3.487

2.  Differential locomotion of long- and short-term IL-2-activated murine natural killer cells in a model matrix environment.

Authors:  P Albertsson; P H Basse; K Edsparr; M H Kim; R H Goldfarb; R H Golfarb; R P Kitson; B Lennernäs; U Nannmark; B R Johansson
Journal:  Scand J Immunol       Date:  2007-10       Impact factor: 3.487

3.  Secreted and membrane-associated matrix metalloproteinases of IL-2-activated NK cells and their inhibitors.

Authors:  M H Kim; R P Kitson; P Albertsson; U Nannmark; P H Basse; P J Kuppen; M E Hokland; R H Goldfarb
Journal:  J Immunol       Date:  2000-06-01       Impact factor: 5.422

4.  The microscopic anatomy of experimental rat CC531 colon tumour metastases: consequences for immunotherapy?

Authors:  M Hagenaars; N G Ensink; P H Basse; M Hokland; U Nannmark; A M Eggermont; C J van de Velde; G J Fleuren; P J Kuppen
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

5.  Tumor structure and extracellular matrix as a possible barrier for therapeutic approaches using immune cells or adenoviruses in colorectal cancer.

Authors:  P J Kuppen; M M van der Eb; L E Jonges; M Hagenaars; M E Hokland; U Nannmark; R H Goldfarb; P H Basse; G J Fleuren; R C Hoeben; C J van de Velde
Journal:  Histochem Cell Biol       Date:  2001-01       Impact factor: 4.304

6.  2B4 stimulation of YT cells induces natural killer cell cytolytic function and invasiveness.

Authors:  S S Chuang; M H Kim; L A Johnson; P Albertsson; R P Kitson; U Nannmark; R H Goldfarb; P A Mathew
Journal:  Immunology       Date:  2000-07       Impact factor: 7.397

7.  Cooperation of urokinase plasminogen activator and matrix metalloproteinases in NK cell invasion.

Authors:  G al-Atrash; R P Kitson; Y Xue; R H Goldfarb
Journal:  In Vivo       Date:  2000 Sep-Oct       Impact factor: 2.155

8.  Expression of matrix metalloproteinases and their inhibitors by rat NK cells: inhibition of their expression by genistein.

Authors:  M H Kim; P Albertsson; Y Xue; R P Kitson; U Nannmark; R H Goldfarb
Journal:  In Vivo       Date:  2000 Sep-Oct       Impact factor: 2.155

9.  Tumor-localization by adoptively transferred, interleukin-2-activated NK cells leads to destruction of well-established lung metastases.

Authors:  Qin Yang; Marianne E Hokland; John L Bryant; Yuquing Zhang; Ulf Nannmark; Simon C Watkins; Ronald H Goldfarb; Ronald B Herberman; Per H Basse
Journal:  Int J Cancer       Date:  2003-07-01       Impact factor: 7.396

10.  Human NK cell lines migrate differentially in vitro related to matrix interaction and MMP expression.

Authors:  Karin Edsparr; Bengt R Johansson; Ronald H Goldfarb; Per H Basse; Ulf Nannmark; Frank M Speetjens; Peter J K Kuppen; Bo Lennernäs; Per Albertsson
Journal:  Immunol Cell Biol       Date:  2009-05-12       Impact factor: 5.126

View more
  8 in total

1.  Generation of BiKEs and TriKEs to Improve NK Cell-Mediated Targeting of Tumor Cells.

Authors:  Martin Felices; Todd R Lenvik; Zachary B Davis; Jeffrey S Miller; Daniel A Vallera
Journal:  Methods Mol Biol       Date:  2016

2.  Membrane-type 6 matrix metalloproteinase regulates the activation-induced downmodulation of CD16 in human primary NK cells.

Authors:  Giovanna Peruzzi; Laurette Femnou; Aleksandra Gil-Krzewska; Francisco Borrego; Jennifer Weck; Konrad Krzewski; John E Coligan
Journal:  J Immunol       Date:  2013-07-12       Impact factor: 5.422

3.  Advanced Glycation End Products and its Soluble Receptors in the Pathogenesis of Thoracic Aortic Aneurysm.

Authors:  Kailash Prasad; Abdullah Sarkar; Mohammad A Zafar; Ahmed Shoker; Hamdi Ei Moselhi; Maryann Tranquilli; Bulat A Ziganshin; John A Elefteriades
Journal:  Aorta (Stamford)       Date:  2016-02-01

4.  Identification of Immune-Related Genes Concurrently Involved in Critical Illnesses Across Different Etiologies: A Data-Driven Analysis.

Authors:  Yaojun Peng; Qiyan Wu; Qing Zhou; Zhanglin Yang; Fan Yin; Lingxiong Wang; Qi Chen; Cong Feng; Xuewen Ren; Tianyi Liu
Journal:  Front Immunol       Date:  2022-05-09       Impact factor: 8.786

Review 5.  The biology of NK cells and their receptors affects clinical outcomes after hematopoietic cell transplantation (HCT).

Authors:  Bree Foley; Martin Felices; Frank Cichocki; Sarah Cooley; Michael R Verneris; Jeffrey S Miller
Journal:  Immunol Rev       Date:  2014-03       Impact factor: 12.988

Review 6.  Stem cells-derived natural killer cells for cancer immunotherapy: current protocols, feasibility, and benefits of ex vivo generated natural killer cells in treatment of advanced solid tumors.

Authors:  Hamid Khodayari; Saeed Khodayari; Elmira Ebrahimi; Farimah Hadjilooei; Miko Vesovic; Habibollah Mahmoodzadeh; Tomo Saric; Wilfried Stücker; Stefaan Van Gool; Jürgen Hescheler; Karim Nayernia
Journal:  Cancer Immunol Immunother       Date:  2021-07-04       Impact factor: 6.968

Review 7.  Natural Killer Cell Adoptive Transfer Therapy: Exploiting the First Line of Defense Against Cancer.

Authors:  Zachary B Davis; Martin Felices; Michael R Verneris; Jeffrey S Miller
Journal:  Cancer J       Date:  2015 Nov-Dec       Impact factor: 3.360

8.  Matrix metalloproteinases in cytotoxic lymphocytes impact on tumour infiltration and immunomodulation.

Authors:  Karin Edsparr; Per H Basse; Ronald H Goldfarb; Per Albertsson
Journal:  Cancer Microenviron       Date:  2010-11-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.